Understanding Long Noncoding RNA and Chromatin Interactions: What We Know So Far

被引:74
|
作者
Mishra, Kankadeb [1 ,2 ]
Kanduri, Chandrasekhar [1 ]
机构
[1] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, S-40530 Gothenburg, Sweden
[2] Mem Sloan Kettering Canc Ctr, Dept Cell Biol, Rockefeller Res Lab, 430 East 67th St,RRL 445, New York, NY 10065 USA
基金
瑞典研究理事会;
关键词
lncrna; chromatin; chromatin RNA; long noncoding RNA; gene regulation; RNA-chromatin interactions; REPEAT-CONTAINING RNA; R-LOOP FORMATION; ANTISENSE TRANSCRIPTION; WIDE IDENTIFICATION; ACTIVE CHROMATIN; BINDING PROTEIN; ENHANCER RNAS; CIRCULAR RNAS; X-CHROMOSOME; MAPS REVEAL;
D O I
10.3390/ncrna5040054
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
With the evolution of technologies that deal with global detection of RNAs to probing of lncRNA-chromatin interactions and lncRNA-chromatin structure regulation, we have been updated with a comprehensive repertoire of chromatin interacting lncRNAs, their genome-wide chromatin binding regions and mode of action. Evidence from these new technologies emphasize that chromatin targeting of lncRNAs is a prominent mechanism and that these chromatin targeted lncRNAs exert their functionality by fine tuning chromatin architecture resulting in an altered transcriptional readout. Currently, there are no unifying principles that define chromatin association of lncRNAs, however, evidence from a few chromatin-associated lncRNAs show presence of a short common sequence for chromatin targeting. In this article, we review how technological advancements contributed in characterizing chromatin associated lncRNAs, and discuss the potential mechanisms by which chromatin associated lncRNAs execute their functions.
引用
收藏
页数:28
相关论文
共 50 条
  • [21] Mesoamerican Nephropathy (MeN): What We Know so Far
    Sanchez Polo, Vicente
    Garcia-Trabanino, Ramon
    Rodriguez, Guillermo
    Madero, Magdalena
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2020, 13 : 261 - 272
  • [22] Tracheal papillomatosis: what do we know so far?
    Harris, Kassem
    Chalhoub, Michel
    CHRONIC RESPIRATORY DISEASE, 2011, 8 (04) : 233 - 235
  • [23] WHAT WE KNOW ABOUT MARIJUANA-SO FAR
    FALTERMA.EK
    FORTUNE, 1971, 83 (03) : 96 - &
  • [24] Carotid Artery Calcification: What We Know So Far
    Ahmed, Madeeha
    McPherson, Regina
    Abruzzo, Alexandra
    Thomas, Sneha E.
    Gorantla, Vasavi Rakesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [25] Building healthy workplaces: What we know so far
    Kelloway, EK
    Day, AL
    CANADIAN JOURNAL OF BEHAVIOURAL SCIENCE-REVUE CANADIENNE DES SCIENCES DU COMPORTEMENT, 2005, 37 (04): : 223 - 235
  • [26] Update on omicron variant: What we know so far
    Choudhary, Gajendra
    Prajapat, Manisha
    Kumaravel, J.
    Prabha, Praisy K.
    Sarma, Phulen
    Handa, Vrishbhanu
    Kaur, Harminder
    Patel, Ajay Prakash
    Medhi, Bikash
    INDIAN JOURNAL OF PHARMACOLOGY, 2022, 54 (01) : 41 - 45
  • [27] Scalp Seborrheic Dermatitis: What We Know So Far
    Leroy, Anne Kelly
    de Almeida, Rita Fernanda Cortez
    Obadia, Daniel Lago
    Frattini, Sidney
    Melo, Daniel Fernandes
    SKIN APPENDAGE DISORDERS, 2023, 9 (03) : 160 - 164
  • [28] HIV and neoplasms: What do we know so far?
    de Souza, Thais Faria
    Sym, Yasmin Vianna
    Chehter, Ethel Zimberg
    EINSTEIN-SAO PAULO, 2023, 21 : eRW0231
  • [29] Neuroproteomics in Epilepsy: What Do We Know so Far?
    do Canto, Amanda M.
    Donatti, Amanda
    Geraldis, Jaqueline C.
    Godoi, Alexandre B.
    da Rosa, Douglas C.
    Lopes-Cendes, Iscia
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2021, 13
  • [30] Strongly Quasiconvex Functions: What We Know (So Far)
    Sorin-Mihai Grad
    Felipe Lara
    Raúl T. Marcavillaca
    Journal of Optimization Theory and Applications, 2025, 205 (2)